Starting from:

$12250

Atopic Dermatitis (Dupixent-Refractory) (U.S.), June 2023

MarketVue®: Dupixent-refractory atopic dermatitis (AD)


The MarketVue®: Dupixent-refractory atopic dermatitis market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market.

Every MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter.